Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Xiaoqing, Zhang Lifan, Zhang Fengchun, Zeng Xiaofeng, Zhao Yan, Wang Qian, Liu Shengyun, Zuo Xiaoxia, Zhang Zhiyi, Wu Huaxiang, Chen Sheng, Li Hongbin, Zhu Ping, Wu Lijun, Qi Wencheng, Liu Yi, Zhang Miaojia, Liu Huaxiang, Xu Dong, Zheng Wenjie, Zhang Yueqiu, Shi Xiaochun, Han Lishuai, Zhou Yaou, Zhao Yanping, Wang Wenwen, Li Ting, Tie Ning, Zhang Kui, Luo Cainan, Gong Baoqi, Zhao Yi, Lv Chengyin, Song Lijun, Wu Qingjun, Fei Yunyun, Zhang Lei, Luo Hui, Sun Jiaying, Xue Jing, Gu Liyang, Wang Jing, Han Qing, Yimaity Kuerbanjiang, Zhou Jiaxin, Zhao Lidan, Bian Sainan, Qi Wufang, Li Yanhong, Zhu Yujing, Han Huijun, Liao Susu, Liu Gaifen
Аннотация
Evidence of active tuberculosis (ATB) in patients with rheumatic diseases are research priorities but limited data from China have been reported. Research targeting patients not taking anti-TNF biologics are especially insufficient. We aimed to investigate the prevalence and risk factors of ATB in this at-risk population. We conducted a tertiary hospital-based, multi-center, cross-sectional study by using stratified multi-stage cluster sampling strategy to screen ATB in patients with rheumatic diseases. We estimated the prevalence of ATB in patients with rheumatic diseases and identified risk factors among those who were not taking anti-TNF biologic. A total of 13,550 eligible patients were enrolled, and the result showed the standardized prevalence of ATB according to the composition ratio of various types of rheumatic disease was 882/100000 (95% confidence interval (CI): 706-1057). Multivariable logistic regression analysis in patients not taking anti-TNF biologics showed that the independent risk factors of ATB were having systemic lupus erythematosus (SLE) (OR=2.722, 95% CI: 1.437-5.159, p=0.002), having Behcet's disease (BD) (OR= 5.261, 95% CI: 2.071-13.365, p<0.001), taking azathioprine(AZA) within the past two years (OR=2.095, 95% CI: 0.986-4.450, p=0.054), exposing to glucocorticoids ≥30mg/d for more than four weeks within the past two years (OR=2.031, 95% CI: 1.247-3.309, p=0.004) and having evidences of previous TB (OR= 6.185, 95% CI: 3.487-10.969, p<0.001). The prevalence of ATB was higher in patients with rheumatic diseases compared to the general population. Patients with SLE or BD, prolonged exposure to moderate to high dose of glucocorticoids and previous TB were independent risk factors for ATB.